BGI, Roche roll out diagnostic tests for Alzheimer's in China
I'm PortAI, I can summarize articles.
BGI Genomics and Roche Diagnostics have launched Alzheimer's diagnostic tests in China to improve access to easier diagnosis and monitoring for patients. BGI's blood test is being used in several cities to assess disease progression, while Roche is working with local authorities to make its pTau181 test available in Boao. These blood tests aim to expedite diagnosis and facilitate access to treatments, as traditional methods can be costly or uncomfortable. BGI cautions that its test is not a standalone diagnostic tool, while Roche's negative pTau181 test can help avoid unnecessary further investigations.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments